Free Trial

Alpha Cognition (ACOG) Competitors

Alpha Cognition logo
$9.67 +0.10 (+1.04%)
As of 04:00 PM Eastern

ACOG vs. GHRS, VECT, KALV, MRVI, SION, BCYC, MNMD, COGT, XNCR, and ETON

Should you be buying Alpha Cognition stock or one of its competitors? The main competitors of Alpha Cognition include GH Research (GHRS), VectivBio (VECT), KalVista Pharmaceuticals (KALV), Maravai LifeSciences (MRVI), Sionna Therapeutics (SION), Bicycle Therapeutics (BCYC), Mind Medicine (MindMed) (MNMD), Cogent Biosciences (COGT), Xencor (XNCR), and Eton Pharmaceuticals (ETON). These companies are all part of the "pharmaceutical products" industry.

Alpha Cognition vs.

Alpha Cognition (NASDAQ:ACOG) and GH Research (NASDAQ:GHRS) are both small-cap medical companies, but which is the better investment? We will contrast the two companies based on the strength of their valuation, media sentiment, analyst recommendations, institutional ownership, risk, dividends, earnings, profitability and community ranking.

GH Research received 31 more outperform votes than Alpha Cognition when rated by MarketBeat users. Likewise, 77.27% of users gave GH Research an outperform vote while only 75.00% of users gave Alpha Cognition an outperform vote.

CompanyUnderperformOutperform
Alpha CognitionOutperform Votes
3
75.00%
Underperform Votes
1
25.00%
GH ResearchOutperform Votes
34
77.27%
Underperform Votes
10
22.73%

Alpha Cognition's return on equity of 0.00% beat GH Research's return on equity.

Company Net Margins Return on Equity Return on Assets
Alpha CognitionN/A N/A -344.17%
GH Research N/A -20.29%-19.49%

Alpha Cognition has a beta of 2.79, meaning that its stock price is 179% more volatile than the S&P 500. Comparatively, GH Research has a beta of 0.97, meaning that its stock price is 3% less volatile than the S&P 500.

Alpha Cognition currently has a consensus target price of $20.00, suggesting a potential upside of 106.83%. GH Research has a consensus target price of $32.00, suggesting a potential upside of 153.77%. Given GH Research's higher probable upside, analysts clearly believe GH Research is more favorable than Alpha Cognition.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Alpha Cognition
0 Sell rating(s)
0 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
3.00
GH Research
0 Sell rating(s)
0 Hold rating(s)
7 Buy rating(s)
0 Strong Buy rating(s)
3.00

In the previous week, GH Research had 4 more articles in the media than Alpha Cognition. MarketBeat recorded 5 mentions for GH Research and 1 mentions for Alpha Cognition. GH Research's average media sentiment score of 0.36 beat Alpha Cognition's score of 0.00 indicating that GH Research is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Alpha Cognition
0 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral
GH Research
0 Very Positive mention(s)
2 Positive mention(s)
2 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral

56.9% of GH Research shares are owned by institutional investors. 14.0% of Alpha Cognition shares are owned by company insiders. Comparatively, 41.6% of GH Research shares are owned by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock will outperform the market over the long term.

Alpha Cognition has higher revenue and earnings than GH Research. GH Research is trading at a lower price-to-earnings ratio than Alpha Cognition, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Alpha Cognition$2.93M52.90-$13.77M-$1.20-8.06
GH ResearchN/AN/A-$35.59M-$0.79-15.96

Summary

GH Research beats Alpha Cognition on 10 of the 15 factors compared between the two stocks.

Get Alpha Cognition News Delivered to You Automatically

Sign up to receive the latest news and ratings for ACOG and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

ACOG vs. The Competition

MetricAlpha CognitionBiological Products IndustryMedical SectorNASDAQ Exchange
Market Cap$154.91M$3.05B$5.46B$8.49B
Dividend YieldN/A1.60%5.26%4.19%
P/E Ratio-3.7832.1527.1119.88
Price / Sales52.90450.75410.33133.76
Price / CashN/A168.6838.2534.64
Price / Book-8.953.356.884.60
Net Income-$13.77M-$72.17M$3.23B$247.54M
7 Day Performance-4.16%4.13%2.42%1.32%
1 Month Performance43.05%6.36%8.02%8.10%
1 Year PerformanceN/A-18.82%27.12%9.83%

Alpha Cognition Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
ACOG
Alpha Cognition
1.0223 of 5 stars
$9.67
+1.0%
$20.00
+106.8%
N/A$154.91M$2.93M-3.78N/A
GHRS
GH Research
1.5342 of 5 stars
$11.17
-0.9%
$30.43
+172.4%
-16.1%$581.15MN/A-14.1410News Coverage
Analyst Forecast
Gap Down
VECT
VectivBio
N/A$16.85
flat
N/AN/A$573.24M$27.34M0.0030High Trading Volume
KALV
KalVista Pharmaceuticals
3.9717 of 5 stars
$11.47
+0.4%
$24.83
+116.5%
+14.2%$570.24MN/A-3.15100News Coverage
Positive News
MRVI
Maravai LifeSciences
3.7374 of 5 stars
$2.22
-3.5%
$6.64
+199.0%
-74.6%$565.35M$241.86M-1.35610
SION
Sionna Therapeutics
N/A$12.72
-2.2%
$38.50
+202.7%
N/A$561.26MN/A0.0035
BCYC
Bicycle Therapeutics
3.1426 of 5 stars
$8.05
-0.6%
$25.00
+210.6%
-62.8%$557.50M$25.72M-2.45240
MNMD
Mind Medicine (MindMed)
1.8973 of 5 stars
$7.30
+3.3%
$25.11
+244.0%
-7.3%$550.19MN/A-3.2340News Coverage
Positive News
COGT
Cogent Biosciences
2.0136 of 5 stars
$4.82
-2.6%
$14.00
+190.5%
-35.9%$548.79MN/A-1.9480
XNCR
Xencor
3.8934 of 5 stars
$7.57
-1.6%
$29.50
+289.7%
-61.3%$538.76M$127.23M-2.37280Positive News
ETON
Eton Pharmaceuticals
3.1537 of 5 stars
$19.81
-2.2%
$29.00
+46.4%
+370.8%$531.27M$48.33M-90.0520Positive News
Short Interest ↓

Related Companies and Tools


This page (NASDAQ:ACOG) was last updated on 6/5/2025 by MarketBeat.com Staff
From Our Partners
OSZAR »